LncTRERNA1 acts as a molecular scaffold to recruit EZH2 and silence its expression through H3K27me3 modification of the promoter region of P21, which is a cyclin-dependent kinase inhibitor, thus promoting cell proliferation and cell cycle progression in diffuse large B-cell lymphoma (DLBCL)111. This evidence concerns the gene EZH2 and diffuse large B-cell lymphoma.